HUT72395A - Improved vaccine for immunisation against tbe virus infections as well as method for preparing them - Google Patents

Improved vaccine for immunisation against tbe virus infections as well as method for preparing them

Info

Publication number
HUT72395A
HUT72395A HU9501832A HU9501832A HUT72395A HU T72395 A HUT72395 A HU T72395A HU 9501832 A HU9501832 A HU 9501832A HU 9501832 A HU9501832 A HU 9501832A HU T72395 A HUT72395 A HU T72395A
Authority
HU
Hungary
Prior art keywords
preparing
well
virus infections
improved vaccine
tbe virus
Prior art date
Application number
HU9501832A
Other languages
English (en)
Other versions
HU9501832D0 (en
HU219503B (hu
Inventor
Steven Allison
Franz Xaver Heinz
Christian Kunz
Christian Mandl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0135294A external-priority patent/AT402897B/de
Priority claimed from AT0087195A external-priority patent/AT405607B/de
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to HU9903233A priority Critical patent/HU224199B1/hu
Publication of HU9501832D0 publication Critical patent/HU9501832D0/hu
Publication of HUT72395A publication Critical patent/HUT72395A/hu
Publication of HU219503B publication Critical patent/HU219503B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24161—Methods of inactivation or attenuation
    • C12N2770/24162—Methods of inactivation or attenuation by genetic engineering
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HU9501832A 1994-07-08 1995-06-21 Javított vakcina TBE-vírusfertőzés elleni immunizálásra, valamint eljárás az előállítására HU219503B (hu)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9903233A HU224199B1 (hu) 1994-07-08 1995-06-21 Flavivírus-fertőzések elleni immunizálásra alkalmas, csupasz nukleinsavat tartalmazó vakcina

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0135294A AT402897B (de) 1994-07-08 1994-07-08 Verbesserte vakzine zur immunisierung gegen tbe-virusinfektionen sowie ein verfahren zu dessen herstellung
AT0087195A AT405607B (de) 1995-05-23 1995-05-23 Verbesserte vakzine zur immunisierung gegen tbe-virusinfektionen sowie ein verfahren zu dessen herstellung

Publications (3)

Publication Number Publication Date
HU9501832D0 HU9501832D0 (en) 1995-08-28
HUT72395A true HUT72395A (en) 1996-04-29
HU219503B HU219503B (hu) 2001-04-28

Family

ID=25594155

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9501832A HU219503B (hu) 1994-07-08 1995-06-21 Javított vakcina TBE-vírusfertőzés elleni immunizálásra, valamint eljárás az előállítására
HU9903233A HU224199B1 (hu) 1994-07-08 1995-06-21 Flavivírus-fertőzések elleni immunizálásra alkalmas, csupasz nukleinsavat tartalmazó vakcina

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9903233A HU224199B1 (hu) 1994-07-08 1995-06-21 Flavivírus-fertőzések elleni immunizálásra alkalmas, csupasz nukleinsavat tartalmazó vakcina

Country Status (9)

Country Link
EP (2) EP0869184B1 (hu)
AT (2) ATE198909T1 (hu)
CZ (1) CZ282927B6 (hu)
DE (2) DE59509667D1 (hu)
DK (2) DK0691404T3 (hu)
ES (2) ES2155510T3 (hu)
FI (2) FI117974B (hu)
HU (2) HU219503B (hu)
RU (1) RU2150294C1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69833388D1 (de) * 1997-11-20 2006-04-13 Us Army Medical Res Materiel C Dna impfstoffe gegen zecken-flavivieren
US7425437B2 (en) 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
NZ535690A (en) 2002-02-26 2009-04-30 Maxygen Inc Novel flavivirus antigens
WO2006067122A2 (en) 2004-12-20 2006-06-29 Crucell Holland B.V. Binding molecules capable of neutralizing west nile virus and uses thereof
WO2006120230A2 (en) 2005-05-12 2006-11-16 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
HUE027099T2 (hu) 2006-06-06 2016-08-29 Crucell Holland Bv Humán kötõmolekulák staphylococcus elleni ölõaktivitással és alkalmazásuk
EP2217716A4 (en) 2007-11-09 2011-02-09 Salk Inst For Biological Studi USE OF TAM RECEPTOR INHIBITORS AS ANTIMICROBIAL AGENTS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074422T3 (es) * 1987-03-20 1995-09-16 Immuno Ag Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
WO1992003161A1 (en) 1990-08-27 1992-03-05 The United States Of America, Represented By The Secretary, United States Department Of Commerce Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
CA2102918C (en) 1992-03-11 2007-05-08 Joel R. Haynes Genetic vaccine for immunodeficiency viruses

Also Published As

Publication number Publication date
CZ176995A3 (en) 1996-01-17
HU9501832D0 (en) 1995-08-28
ES2155510T3 (es) 2001-05-16
FI117974B (fi) 2007-05-15
EP0691404A2 (de) 1996-01-10
DK0691404T3 (da) 2001-03-19
FI118222B (fi) 2007-08-31
ATE198909T1 (de) 2001-02-15
EP0869184A3 (de) 1999-05-12
RU2150294C1 (ru) 2000-06-10
FI953371A0 (fi) 1995-07-07
EP0691404A3 (de) 1997-11-12
HU9903233D0 (en) 1999-11-29
FI953371A (fi) 1996-01-09
CZ282927B6 (cs) 1997-11-12
DK0869184T3 (da) 2001-12-17
DE59508988D1 (de) 2001-03-01
ES2165109T3 (es) 2002-03-01
HU224199B1 (hu) 2005-06-28
EP0691404B1 (de) 2001-01-24
DE59509667D1 (de) 2001-11-08
EP0869184B1 (de) 2001-10-04
ATE206459T1 (de) 2001-10-15
EP0869184A2 (de) 1998-10-07
HU219503B (hu) 2001-04-28
FI20070041A (fi) 2007-01-17

Similar Documents

Publication Publication Date Title
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
HU9603155D0 (en) Papillomavirus vaccines
ZA8997B (en) Recombinant vaccinia virus mva
EP1847549A3 (en) Papillomavirus polyprotein constructs
ATE215124T1 (de) Rekombinante tetc-fusionsprotein enthaltene impfstoffzusammensetzungen
FI20070041A (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
AU580059B2 (en) Vaccine against rabies and preparation process thereof
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
DE69836520D1 (de) Clostridium perfringens Impfstoff
KR100207354B1 (en) Recombinant coccidiosis vaccines-5-7-eimeria surface antigen and a method for protecting poultry against coccidiosis using the same
NZ238833A (en) Equine herpesvirus-4 gh or gc polypeptides, nucleic acids encoding them and vaccines therefrom
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
GB9818133D0 (en) Vaccine
IL82720A0 (en) Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions
GB9401795D0 (en) Vaccines

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees